JP2021536474A5 - - Google Patents
Info
- Publication number
- JP2021536474A5 JP2021536474A5 JP2021512694A JP2021512694A JP2021536474A5 JP 2021536474 A5 JP2021536474 A5 JP 2021536474A5 JP 2021512694 A JP2021512694 A JP 2021512694A JP 2021512694 A JP2021512694 A JP 2021512694A JP 2021536474 A5 JP2021536474 A5 JP 2021536474A5
- Authority
- JP
- Japan
- Prior art keywords
- sustained
- pharmaceutical composition
- therapeutic agent
- ophthalmic pharmaceutical
- release ophthalmic
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862729038P | 2018-09-10 | 2018-09-10 | |
| US62/729,038 | 2018-09-10 | ||
| PCT/US2019/050135 WO2020055713A1 (en) | 2018-09-10 | 2019-09-09 | Sustained-release ophthalmic pharmaceutical compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536474A JP2021536474A (ja) | 2021-12-27 |
| JP2021536474A5 true JP2021536474A5 (https=) | 2022-09-08 |
| JPWO2020055713A5 JPWO2020055713A5 (https=) | 2022-09-08 |
Family
ID=69778306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512694A Ceased JP2021536474A (ja) | 2018-09-10 | 2019-09-09 | 徐放性眼科用医薬組成物およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210275447A1 (https=) |
| EP (1) | EP3849523A4 (https=) |
| JP (1) | JP2021536474A (https=) |
| CN (1) | CN112654345A (https=) |
| TW (1) | TWI786328B (https=) |
| WO (1) | WO2020055713A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2025146683A1 (en) | 2024-01-03 | 2025-07-10 | Lyotropic Delivery Systems Ltd. | Topical formulations for delivery of an active compound to the back of the eye |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2340118C (en) * | 1998-08-12 | 2009-01-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| US8753673B2 (en) * | 2006-05-23 | 2014-06-17 | Taiwan Liposome Co. Ltd. | Liposome composition for delivery of a therapeutic agent to eyes |
| US20080118500A1 (en) * | 2006-11-16 | 2008-05-22 | Taiwan Liposome Company | Sustained releasing composition via local injection for treating eye diseases |
| CN101199505B (zh) * | 2007-12-20 | 2012-05-23 | 沈阳药科大学 | 维拉帕米脂质体及其制备方法 |
| CN101601654B (zh) * | 2009-07-03 | 2010-08-18 | 王明 | 盐酸法舒地尔脂质体注射剂及其新应用 |
| CN102485212B (zh) * | 2010-12-01 | 2014-04-09 | 沈阳药科大学 | 苹果酸舒尼替尼脂质体及其制备方法 |
| DK2968146T3 (da) * | 2013-03-15 | 2020-03-16 | Taiwan Liposome Co Ltd | Liposomsammensætning med kontrolleret lægemiddelfrigivelse |
| EP3177269A4 (en) * | 2014-08-04 | 2018-02-28 | Zoneone Pharma, Inc. | Remote loading of sparingly water-soluble drugs into lipid vesicles |
| TWI700085B (zh) * | 2015-06-22 | 2020-08-01 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物的用途 |
| CN108295072A (zh) * | 2015-12-09 | 2018-07-20 | 瑞阳(苏州)生物科技有限公司 | 尼达尼布防治眼部疾病的用途 |
| CN108601746B (zh) * | 2016-01-08 | 2024-09-13 | 加利福尼亚大学董事会 | 用于运载物递送的具有脂质双层包衣的中孔二氧化硅纳米颗粒 |
| CN106727325A (zh) * | 2016-12-29 | 2017-05-31 | 青岛黄海制药有限责任公司 | 一种甲磺酸伊马替尼的脂质体制剂及其制备方法 |
| CN112004527B (zh) * | 2018-04-23 | 2024-09-24 | 盈擘生技股份有限公司 | 用于治疗肺部疾病的可吸入脂质体缓释组合物 |
| WO2020023445A1 (en) * | 2018-07-24 | 2020-01-30 | Taiwan Liposome Co., Ltd. | Sustained-release pharmaceutical compositions comprising a therapeutic agent for treating dementia and uses thereof |
-
2019
- 2019-09-09 WO PCT/US2019/050135 patent/WO2020055713A1/en not_active Ceased
- 2019-09-09 JP JP2021512694A patent/JP2021536474A/ja not_active Ceased
- 2019-09-09 TW TW108132404A patent/TWI786328B/zh active
- 2019-09-09 US US17/270,747 patent/US20210275447A1/en not_active Abandoned
- 2019-09-09 EP EP19859911.0A patent/EP3849523A4/en not_active Withdrawn
- 2019-09-09 CN CN201980058490.1A patent/CN112654345A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI866908B (zh) | 用於治療肺部疾病的可吸入的緩釋組成物 | |
| JP2019023243A5 (https=) | ||
| RU2660585C2 (ru) | Фармацевтическая композиция для уменьшения осложнений применения стероидных препаратов при лечении офтальмологических заболеваний | |
| TW201105350A (en) | Ophthalmic drug delivery system containing phospholipid and cholesterol | |
| JP2021536474A5 (https=) | ||
| RU2014120216A (ru) | Комбинационные липосомальные композиции для лечения рака | |
| CN116635009A (zh) | 用于递送抗癌剂的具有改进的治疗指数的组合物和方法 | |
| RU2005115956A (ru) | Способ лечения инсулинорезистентности, диабета взрослых и метаболического синдрома х | |
| JP6230538B2 (ja) | 安定なオキサリプラチン封入リポソーム水分散液及びその安定化方法 | |
| JP2019516693A5 (https=) | ||
| TWI767133B (zh) | 含有治療憂鬱症或焦慮症之治療劑的緩釋組合物及其用途 | |
| JP2019515925A (ja) | 炎症性病変又は領域に局所注射するためのリポソーム化コルチコステロイド | |
| TWI786328B (zh) | 緩釋眼用藥物組合物及其用途 | |
| ES3058285T3 (en) | Pharmaceutical compositions with reduced side effect and methods of using the same | |
| JP2023030106A5 (https=) | ||
| JPWO2020055713A5 (https=) | ||
| US9078812B2 (en) | Particulate drug carriers as desensitizing agents | |
| JPWO2023009422A5 (https=) | ||
| TW202143978A (zh) | 格列本脲脂質體組合物及其製備方法 | |
| KR101305721B1 (ko) | 신생 혈관 생성 및 신생 림프관 생성 억제를 위한 설린닥의 신규한 제형 및 이를 포함하는 안질환의 치료용 조성물 | |
| US20070148225A1 (en) | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE | |
| TW202220668A (zh) | 用於疼痛控制之關節內皮質類固醇的藥學組成物 | |
| HK1242192A1 (en) | Pharmaceutical compositions to reduce complications of ocular steroid | |
| JPWO2023041569A5 (https=) | ||
| HK1201723B (en) | Pharmaceutical compositions to reduce complications of ocular steroid |